Welcome to the Desert Angels™. We are a Tucson, Arizona based non-profit organization of accredited investors who seek opportunities to invest in Southwest regional startup or early stage companies. The organization serves as a forum for its over 70 members, who invest individually from their personal funds. Since 2000, Desert Angel members have invested over $40 million in more than 95 presenting companies.

Tempe tech startup raises $1 million in seed round

by Curtis Gunn on March 22nd, 2017 at 4:44pm

Tempe tech startup Prospectify.io has raised $1 million in a seed round to expand its staff, its software and its customers.

Prospectify helps business-to-business salespeople identify the right companies to target, and the relevant contacts at those companies, while delivering messaging to them when they’re most likely to buy, said Matt Ekstrom, co-founder and chief revenue officer.

“Our customers buy from us the ability to search a database of companies based on 40 different data points on companies, from their business model to revenue, to the technology they use,” Ekstrom said. “Then pair that with the type of prospect profiles they’re looking for.”

Read full article here

Comment

Filed under: Uncategorized

NuvOx Pharma and the University of Arkansas Initiate Phase Ib/II Clinical Trial in Stroke

by Curtis Gunn on March 6th, 2017 at 6:10pm

NuvOx Pharma announces that the first patients have been dosed in a Phase Ib/II clinical trial for NVX-208, an oxygen therapeutic being developed for acute ischemic stroke. The trial is being performed at the University of Arkansas for Medical Sciences in Little Rock, Arkansas, under the direction of Dr. William Culp, the Jonathan Fitch Distinguished Chair in Stroke. Culp said, “We have studied NVX-208 in a number of pre-clinical stroke models and found that administration of NVX-208 decreases the brain damage from stroke by over 80%. The only approved drug to treat stroke is the thrombolytic drug t-PA, which has a risk of bleeding and is approved for use only up to 3 hours following stroke. Administration of NVX-208 prior to t-PA extended the time window of efficacy to at least nine hours.”

Read full article here

Comment

Filed under: Uncategorized

HTG Molecular Diagnostics Unveils New Direct-Target Sequencing Chemistry to Launch in First Quarter 2017

by Curtis Gunn on March 2nd, 2017 at 6:07pm

HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM)(“HTG”), a provider of instruments, reagents and services for molecular profiling applications announced that its new direct-target sequencing chemistry will be available in the company’s VERI/O laboratory as a service offering beginning in the first quarter of 2017. The new chemistry is designed for direct sequencing of specified DNA and, in the future, RNA targets with the same high sensitivity and specificity as the company’s current HTG EdgeSeq chemistry applications. The initial panel planned for the VERI/O laboratory will detect common mutations in the EGFR, KRAS and BRAF genes for retrospective research studies especially from small and difficult samples, such as formalin-fixed, paraffin-embedded (FFPE) tissue.

Read full article here

Comment

Filed under: Uncategorized

UA startup receives funding for computer data error correction

by Curtis Gunn on February 16th, 2017 at 6:20pm

Every day millions of people are uploading, texting and sharing information online, but consider where and how this information is being stored. Codelucida, a startup largely based on research done at the UA, has developed an innovative technology to enhance the efficiency and reliability of data storage products.

According to the Department of Energy, there are 3 million data centers in the U.S., which adds up to about one center for every 100 people. These centers are continually processing and storing information and constantly using an exorbitant amount of energy. In order to serve their needs, Codelucida is in the process of using recent investment to fund commercial scale distribution of their error-correction technology.

The company was recently funded $700,000 to market this data storage technology by angel investment groups, including Tucson’s Desert Angels, Tech Coast Angels and Arizona’s Tech Investors. This adds to their previous funding of $900,000 from the National Science Foundation.

Read full article here

Comment

Filed under: Uncategorized

CampusLogic Acquires Cegment, Adds the Leading Cost Calculator to Improve Transparency and Engagement Throughout the Student Financial Aid Experience

by Curtis Gunn on February 16th, 2017 at 6:08pm

CampusLogic announces the acquisition of Cegment’s Net Price Calculator (NPC) and Award Letter business. A pioneer in the NPC business, Cegment helps create transparency in higher education financing so families can better understand and assess the cost of a college degree. The integration of Cegment with the CampusLogic platform will form the only end-to-end student financial aid engagement platform designed to increase accessibility to education, reduce student borrowing, and drive down the cost of financial aid administration.

Read full article here

Comment

Filed under: Uncategorized

20 MOLECULAR DIAGNOSTICS COMPANIES TO WATCH

by Curtis Gunn on February 8th, 2017 at 6:15pm

The molecular diagnostics market is growing, though projections on how fast and how far vary depending on who is studying the field. Grand View Research in October projected a near-tripling of the market to $17.9 billion in 2024, from $6.45 billion in 2015.

That’s just slightly lower than the $6.54 billion market size estimated for molecular diagnostics last year by MarketsAndMarkets, which foresees the field climbing to $10.12 billion by 2021. A third company, Global Market Insights, sees a slightly smaller market of $10.03 billion by 2023.

Read full article here

Comment

Filed under: Funded Companies, Press

UA Startup Codelucida Secures $700K in Angel Funding

by Curtis Gunn on February 3rd, 2017 at 9:04pm

Codelucida, a University of Arizona startup that is commercializing error-correction technology for data storage and communications, has reported that it has raised approximately $700,000 in a round of angel investment funding. The effort, led by Tucson’s Desert Angels, also pulled together participation from the Tech Coast Angels in Southern California, the Arizona Tech Investors in Phoenix and other private angel investors.

Read full article here

Comment

Filed under: Uncategorized

NuvOx Pharma and Jiangsu Nhwa Pharmaceutical Co., Ltd. Sign Licensing Agreement for Hemorrhagic Shock and Perioperative Blood Loss

by Curtis Gunn on January 26th, 2017 at 5:46pm

NuvOx Pharma LLC and Jiangsu Nhwa Pharmaceutical Co., Ltd. have signed a licensing agreement for the exclusive development and sales of NVX-408 for China for treating hemorrhagic shock and perioperative blood loss.

NVX-408 is an oxygen therapeutic that is injected intravenously, flows through the lungs and picks up oxygen, then flows through the blood and passes hypoxic tissue then releases oxygen. Pre-clinical studies show that it can improve survival during severe blood loss.

Read full article here

Comment

Filed under: Uncategorized

Codelucida Announces Closing of a Syndicated Angel Investment Round Led by Desert Angels

by Curtis Gunn on January 24th, 2017 at 7:40pm

Codelucida recently announced the successful closing of a seed round of angel investment led by Tucson-based Desert Angels in syndication with Southern California-based Tech Coast Angels, Phoenix-based Arizona Tech Investors, and other private angel investors. This funding adds to the $750,000 that the company previously received through a Small Business Innovation Research (SBIR) Phase-2 award from the National Science Foundation (NSF) in August of 2015.

Read full article here

Comment

Filed under: Uncategorized

New ASU ed-tech accelerator announces first cohort group

by Curtis Gunn on January 23rd, 2017 at 7:46pm

A new Arizona State University ed-tech accelerator designed to move education technology to market faster has announced the program’s first business cohorts.

The ASU Draper GSV Accelerator allows new ventures to be tested by ASU students and faculty, with the plan to allow the technology to move to market faster.

Read full article here

Comment